Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 263.23 USD -0.04% Market Closed
Market Cap: 18.5B USD
Have any thoughts about
Insulet Corp?
Write Note

Insulet Corp
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Insulet Corp
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Insulet Corp
NASDAQ:PODD
Goodwill
$51.7m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
3%
Becton Dickinson and Co
NYSE:BDX
Goodwill
$37.4B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
42%
Boston Scientific Corp
NYSE:BSX
Goodwill
$15B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Goodwill
$16.4B
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
14%
Abbott Laboratories
NYSE:ABT
Goodwill
$23.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Goodwill
$348.3m
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
6%
No Stocks Found

Insulet Corp
Glance View

Market Cap
18.5B USD
Industry
Health Care
Economic Moat
Narrow

Insulet Corporation has carved out a significant niche in the medical device industry, distinguishing itself through its innovative approach to diabetes management. The company is best known for its Omnipod Insulin Management System, a discreet, tubeless insulin pump that provides a solution for individuals with diabetes seeking an alternative to traditional insulin delivery methods. Unlike conventional pumps that require cumbersome tubes and significant patient involvement, the Omnipod system offers ease and convenience, allowing users more freedom and flexibility in their daily lives. The system operates via a small wearable pod that delivers insulin over several days, which users control remotely, removing much of the hassle associated with managing diabetes. Insulet generates revenue by selling these pods and the associated Personal Diabetes Manager (PDM) devices, which together comprise the entire system. Customers typically purchase pods on a recurring basis, similar to a subscription model, which creates a steady stream of revenue for the company. The business model emphasizes continuous growth by expanding its user base and improving its technology to remain at the forefront of patient-centric diabetes care. Insulet's strategic focus on the needs of its users and commitment to refining their health technology has enabled it to build a sustainable business that addresses a critical healthcare challenge while also delivering consistent financial performance.

PODD Intrinsic Value
98.7 USD
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Insulet Corp's Goodwill?
Goodwill
51.7m USD

Based on the financial report for Sep 30, 2024, Insulet Corp's Goodwill amounts to 51.7m USD.

What is Insulet Corp's Goodwill growth rate?
Goodwill CAGR 10Y
3%

Over the last year, the Goodwill growth was 0%. The average annual Goodwill growth rates for Insulet Corp have been 9% over the past three years , 5% over the past five years , and 3% over the past ten years .

Back to Top